Enliven Therapeutics (ELVN) Earnings Date & Reports
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
ELVN is expected to report earnings to rise 8.76% to -50 cents per share on May 08
Q1'25
Est.
$-0.50
Q4'24
Beat
by $0.06
Q3'24
Beat
by $0.03
Q2'24
Beat
by $0.14
Q1'24
Est.
$-0.54
The last earnings report on March 13 showed earnings per share of -46 cents, beating the estimate of -51 cents. With 223.68K shares outstanding, the current market capitalization sits at 983.52M.